Printer Friendly

MARION MERRELL DOW INC. AWARDS LABORATORY DESIGN WORK TO JACOBS

 CINCINNATI, Feb. 11 /PRNewswire/ -- Jacobs Engineering Group Inc. (NYSE: JEC) announced today that they have received a contract to design a new $8 million research and development laboratory at Marion Merrell Dow's Cincinnati research facility. The new facility will provide 27,300 square feet of space for general chemistry, radio chemistry, and a small scale pilot plant operations.
 The value of the Jacobs contract was not disclosed.
 In order to provide natural lighting for each laboratory, the facility will be designed to conform to an "H"-shaped configuration. Individual laboratories in the building are accessible from central, double-loaded corridors running the length of each leg.
 Jacobs Engineering Group, headquartered in Pasadena, Calif., provides single-source consulting, engineering, design, architectural, enviroes to government and industry worldwide. Jacobs has 22 offices located throughout the United States, United Kingdom and Ireland with its Midwest Regional Headquarters located in Cincinnati.
 -0- 2/11/93
 /CONTACT: Phil Stassi of Jacobs Engineering, 818-578-6902/
 (JEC)


CO: Jacobs Engineering Group Inc.; Marion Merrell Dow Inc. ST: Ohio, California IN: CST SU: CON

MS-JB -- LA001 -- 5504 02/11/93 08:06 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1993
Words:182
Previous Article:DOW DECLARES QUARTERLY DIVIDEND
Next Article:TENNANT COMPANY REPORTS HIGHER SALES FOR 1992; ACCOUNTING CHANGE REDUCES EARNINGS
Topics:


Related Articles
IMMULOGIC AND MARION MERRELL DOW SIGN COLLABORATION AGREEMENT TO COMMERCIALIZE IMMULOGIC'S ALLERVAX ALLERGY PRODUCTS
ALTEON AND MARION MERRELL DOW EXPAND COLLABORATION ON DRUGS FOR DIABETES AND AGING
IMMULOGIC AND MARION MERRELL DOW SIGN FINAL ALLERVAX PRODUCT COMMERCIALIZATION AGREEMENT
SCIOS INC. AND MARION MERRELL DOW SIGN MAJOR RESEARCH AND DEVELOPMENT AGREEMENT TO DEVELOP NEW THERAPIES FOR ALZHEIMER'S DISEASE
MARION MERRELL DOW COMMITS TO MAJOR EXPANSION OF AFFYMAX ALLIANCE
MARION MERRELL DOW INC. AND MITSUBISHI KASEI CORP. ANNOUNCE NORTH AMERICAN COLLABORATION
MARION MERRELL DOW IN-LICENSES TWO DRUGS IN LATE-STAGE TRIALS FROM MERCK & CO.
SANDOZ AND MARION MERRELL DOW ANNOUNCE CO-PROMOTION ARRANGEMENT
RUGBY LABORATORIES REACHES AGREEMENT TO REGISTER AND SELL PRODUCTS IN RUSSIA
ONCOGENE SCIENCE, INC. AND MARION MERRELL DOW COLLABORATIVE PROGRAM ADVANCES

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters